• Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Slide title

    Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Button
  • Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Slide title

    Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Button

Service Offerings

ADMET (IN VITRO)
BIOANALYSIS (GLP/GCP, Discovery)
Clinical Pathology
Biomarker
DMPK (IN VIVO)
Histology
IN SILICO DRUG DISCOVERY
TOXICOLOGY (NON-GLP/GLP)

Therapeutic Areas

Services By Developmental Phase

Latest News

Who We Are

About us

Pharmidex is a contract research organisation (CRO) that provides translational solutions using its world-renowned expertise in CNS, oncology, respiratory, DMPK, drug discovery and ADMET/pharmacokinetics.


Founded in the UK, in 2002, Pharmidex operates in state-of-the-art facilities in Hertfordshire to provide high-quality experimental data and expert guidance to support drug discovery and development.

Home

Key Facts

Experts in therapeutic preclinical models 


Accredited by AAALAC and the MHRA to perform GLP and GCP certified services

Home

Services

Single site service offering with 15,000+ studies conducted to date


Quick turnaround times, cost effective research, expert interpretation and customer-focused approach

Home

Our History

Successfully helped multiple clients reach clinical development since 2002

News

DMPK Services News! More News!

🔴 Today is World Blood Cancer Day 🔴

May 28, 2025
At Pharmidex , we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers. This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases. Through our cutting-edge preclinical services, including: PK/ADME studies CNS penetration & efficacy models in vivo/in vitro pharmacology bioanalytical and regulatory support  we contribute to the development of safer, more effective therapies for blood cancers. 🧬 We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments. ❤️ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure. 🔗 Learn more and support the cause: https://www.dkms.org.uk

🎉 Innovation Spotlight at Pharmidex! 🎉

May 27, 2025
We are proud to announce the integration of the Jess™ / Wes™ Automated Western Blotting Systems by Bio-Techne into our platform bringing next-generation protein analysis capabilities to our drug discovery and development workflows. These Simple Western™ systems transform traditional Western blotting by automating and streamlining the entire process, delivering: ✅ High sensitivity and quantitation down to picogram levels ✅ Hands-free automation with results in just 3 hours ✅ Reproducible, publication-quality data ✅ Minimal sample and reagent use ✅ Multiplex detection with chemiluminescence or fluorescence This technology allows Pharmidex to generate fast, reproducible and quantitative protein data, enabling our clients and collaborators to accelerate biomarker validation, mechanism-of-action studies, and more. Another step forward in our mission to support smarter, faster drug development.
PK/PD

Powering smarter drug development with precision PK/PD and bioanalysis

May 20, 2025
At Pharmidex , we help drug developers move faster and smarter with high-quality PK/PD assessments and bioanalytical services across a range of therapeutic areas. 🔬 Our team combines: Bespoke In vivo PK/PD & CNS penetration studies Wild-type, immunodeficient & humanised rodent models Advanced platforms: LC-MS/MS, qPCR, ELISA 🧠 Whether you're working on CNS drugs, oncology assets, or rare disease therapies, we deliver high quality data to drive confident decisions from lead optimisation to IND-enabling studies. ✨ Need to evaluate: BBB penetration? Target tissue exposure? PK profiling of small molecules or biologics? We’ve got you covered. 📨 Let’s talk see how Pharmidex can support your next breakthrough: 🌐 www.pharmidex.com
Services by Department